{
  "zip": "75012",
  "sector": "",
  "fullTimeEmployees": 98,
  "longBusinessSummary": "Nanobiotix SA operates as a clinical-stage nanomedicine company for the treatment of cancer worldwide. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. It offers NBTXR3, a radio-enhancer hafnium oxide for the treatment of solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, glioblastoma, and other cancers. Nanobiotix SA was incorporated in 2003 and is headquartered in Paris, France.",
  "city": "Paris",
  "phone": "33 1 40 26 04 70",
  "country": "France",
  "companyOfficers": [],
  "website": "http://www.nanobiotix.com",
  "maxAge": 1,
  "address1": "60 rue de Wattignies",
  "fax": "33 1 40 26 04 44",
  "industry": "",
  "previousClose": 17.25,
  "regularMarketOpen": 17.25,
  "twoHundredDayAverage": 9.653802,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 17.25,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 17.25,
  "fiftyDayAverage": 16.204494,
  "trailingAnnualDividendRate": null,
  "open": 17.25,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 2.039325,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 17.25,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 20,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": null,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 87,
  "priceToSalesTrailing12Months": null,
  "dayLow": 17.25,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 20,
  "fiftyTwoWeekHigh": 17.6,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 7.32,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 17.25,
  "exchange": "PNK",
  "shortName": "NANOBIOTIX",
  "longName": "Nanobiotix S.A.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "NNBXF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_20950715",
  "uuid": "97635ebc-af99-3b50-b406-5a7c95cd43ee",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": null,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.13313,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.0694,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 20667594,
  "enterpriseValue": 391719872,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 17.25,
  "logo_url": "https://logo.clearbit.com/nanobiotix.com"
}